Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: A Clinical Study of TQH2929 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study of TQH2929 in healthy adult subjects has completed, with psoriasis listed as the condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TQH2929

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED